Assignee
PROLX PHARMACEUTICALS CORP
US·5 granted patents·1 pending application·56 citations·filing 1998–2010
Top patents by PatentIndex Score
6 records- 0188US7446124B2Wortmannin analogs and methods of using same in combination with chemotherapeutic agentsPROLX PHARMACEUTICALS CORP·Filed 2005·Granted Nov 4, 2008·12 cites·25 claims
- 0283US7399785B2N-oxides and derivatives of melphalan for treating diseased states associated with hypoxia inducible factorPROLX PHARMACEUTICALS CORP·Filed 2004·Granted Jul 15, 2008·18 cites·19 claims
- 0381US7858657B2Wortmannin analogs and methods of using same in combination with chemotherapeutic agentsPROLX PHARMACEUTICALS CORP·Filed 2008·Granted Dec 28, 2010·1 cites·8 claims
- 0462US7629128B2Methods of identifying respondents to hypoxia inducible factor 1-α inhibitorsPROLX PHARMACEUTICALS CORP·Filed 2006·Granted Dec 8, 2009·1 cites·5 claims
- 0560US6372772B1Inhibitors of redox signaling and methods of using samePROLX PHARMACEUTICALS CORP·Filed 1998·Granted Apr 16, 2002·24 cites·4 claims
- 0656US2011110941A1Wortmannin Analogs and Methods of Using Same in Combination with Chemotherapeutic AgentsPROLX PHARMACEUTICALS CORP·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PROLX PHARMACEUTICALS CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →